(17)
‘Subject’ means an individual who participates in a clinical trial, either as recipient of an investigational medicinal product or as a control;
← art_2__para_2__point_16__text_1 · All articles · art_2__para_2__point_17__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.